Muro K - Search Results

1

Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G).

Izawa N, Shitara K, Yonesaka K, Yamanaka T, Yoshino T, Sunakawa Y, Masuishi T, Denda T, Yamazaki K, Moriwaki T, Okuda H, Kondoh C, Nishina T, Makiyama A, Baba H, Yamaguchi H, Nakamura M, Hyodo I, Muro K, Nakajima TE. Izawa N, et al. Among authors: muro k. Target Oncol. 2020 Oct;15(5):623-633. doi: 10.1007/s11523-020-00750-w. Target Oncol. 2020. PMID: 32960408 Clinical Trial.

2

Prediction of in vivo drug-drug interactions based on mechanism-based inhibition from in vitro data: inhibition of 5-fluorouracil metabolism by (E)-5-(2-Bromovinyl)uracil.

Kanamitsu SI, Ito K, Okuda H, Ogura K, Watabe T, Muro K, Sugiyama Y. Kanamitsu SI, et al. Among authors: muro k. Drug Metab Dispos. 2000 Apr;28(4):467-74. Drug Metab Dispos. 2000. PMID: 10725316 Clinical Trial.

3

Effect of a 3-hour interval between methotrexate and 5-fluorouracil in the treatment of metastatic colorectal cancer.

Matsumura Y, Haruyama K, Hamaguchi T, Shirao K, Muro K, Yamada Y, Shimada Y, Sugano K. Matsumura Y, et al. Among authors: muro k. Jpn J Clin Oncol. 2002 Jan;32(1):9-13. doi: 10.1093/jjco/hyf007. Jpn J Clin Oncol. 2002. PMID: 11932356 Clinical Trial.

4

Prognostic factors for patients with metastatic colorectal cancer receiving protracted venous infusion of 5-FU.

Namiki Y, Muro K, Shirao K, Shimada Y, Matsumura Y, Yamada Y, Gotoh M, Hamaguchi T, Mizuno T, Ura T. Namiki Y, et al. Among authors: muro k. Am J Clin Oncol. 2002 Apr;25(2):182-6. doi: 10.1097/00000421-200204000-00017. Am J Clin Oncol. 2002. PMID: 11943899

5

Weekly hepatic arterial infusion of 5-fluorouracil and subsequent systemic chemotherapy for liver metastases from colorectal cancer.

Hosokawa A, Yamada Y, Shimada Y, Muro K, Matsumura Y, Fujita S, Akasu T, Moriya Y, Shirao K. Hosokawa A, et al. Among authors: muro k. Jpn J Clin Oncol. 2003 Mar;33(3):132-5. doi: 10.1093/jjco/hyg021. Jpn J Clin Oncol. 2003. PMID: 12672790

6

Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer.

Yamada Y, Yasui H, Goto A, Arai T, Ura T, Hamaguchi T, Muro K, Shimada Y, Shirao K. Yamada Y, et al. Among authors: muro k. Int J Clin Oncol. 2003 Dec;8(6):374-80. doi: 10.1007/s10147-003-0359-z. Int J Clin Oncol. 2003. PMID: 14663640 Clinical Trial.

7

A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer.

Muro K, Hamaguchi T, Ohtsu A, Boku N, Chin K, Hyodo I, Fujita H, Takiyama W, Ohtsu T. Muro K, et al. Ann Oncol. 2004 Jun;15(6):955-9. doi: 10.1093/annonc/mdh231. Ann Oncol. 2004. PMID: 15151954 Free article. Clinical Trial.

8

Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.

Shirao K, Hoff PM, Ohtsu A, Loehrer PJ, Hyodo I, Wadler S, Wadleigh RG, O'Dwyer PJ, Muro K, Yamada Y, Boku N, Nagashima F, Abbruzzese JL. Shirao K, et al. Among authors: muro k. J Clin Oncol. 2004 Sep 1;22(17):3466-74. doi: 10.1200/JCO.2004.05.017. Epub 2004 Jul 26. J Clin Oncol. 2004. PMID: 15277535 Clinical Trial.

9

Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer.

Goto A, Yamada Y, Hosokawa A, Ura T, Arai T, Hamaguchi T, Muro K, Shimada Y, Shirao K. Goto A, et al. Among authors: muro k. Int J Clin Oncol. 2004 Oct;9(5):364-8. doi: 10.1007/s10147-004-0407-3. Int J Clin Oncol. 2004. PMID: 15549585 Clinical Trial.

10

Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracil.

Hosokawa A, Yamada Y, Shimada Y, Muro K, Hamaguchi T, Morita H, Araake M, Orita H, Shirao K. Hosokawa A, et al. Among authors: muro k. Int J Clin Oncol. 2004 Oct;9(5):388-92. doi: 10.1007/s10147-004-0425-1. Int J Clin Oncol. 2004. PMID: 15549590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

573 results

Search Page

Filters